ArticleCancer immunology, immunotherapy : CII2026
TGF-β inhibition enhances anti-tumor immunity and sensitizes PD-1 blockade therapy of bone marrow-derived myofibroblasts-induced "immunotherapy resistance" tumor model.
Xin Cheng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.